14872219

Source:http://linkedlifedata.com/resource/pubmed/id/14872219

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021027, umls-concept:C0035435, umls-concept:C0087111, umls-concept:C0392360
pubmed:issue	4
pubmed:dateCreated	2004-2-11
pubmed:language	ita
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401302
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, Intravenous
pubmed:status	MEDLINE
pubmed:issn	0048-7449
pubmed:author	pubmed-author:BellisaiFF, pubmed-author:CapecchiP LPL, pubmed-author:GaleazziMM, pubmed-author:Laghi PansiniFF, pubmed-author:LazzeriniP EPE
pubmed:issnType	Print
pubmed:volume	55
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	209-19
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:14872219-Antiphospholipid Syndrome, pubmed-meshheading:14872219-Forecasting, pubmed-meshheading:14872219-Humans, pubmed-meshheading:14872219-Immunoglobulins, Intravenous, pubmed-meshheading:14872219-Lupus Erythematosus, Systemic, pubmed-meshheading:14872219-Lupus Nephritis, pubmed-meshheading:14872219-Rheumatic Diseases, pubmed-meshheading:14872219-Vasculitis
pubmed:articleTitle	[Indications for intra-venous immunoglobulin treatment in rheumatic diseases].
pubmed:publicationType	Editorial, Review